Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 11, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$4.46B
sum of reported positions
Reported positions
488
Changes vs prior quarter
484
37 new · 38 exited
Filings on record
7
Q2 2026, Q1 2026, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 191 measured positions in 6 quarters, the typical new or larger position finished −1.9 pts against the S&P 500 and 45% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 4.72M | $360M | 8.1% | |
| 606K | $263M | 5.9% | |
| 427K | $248M | 5.6% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
In its latest 13F, with holdings as of Jun 30, 2026 (Q2 2026), E Fund Management Co., Ltd. reported 488 positions worth $4.46B. The largest: Pdd (PDD), 8.1%; Lam Research (LRCX), 5.9%; AMD (AMD), 5.6%; NVIDIA (NVDA), 5.3%; Intel (INTC), 4.7%. The five largest make up 29% of the reported portfolio.
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $3.37B | $4.46B |
| Positions | 489 | 488 |
| Biggest line | — | Pdd 8% |
| 1.17M |
| $235M |
| 5.3% |
| 1.5M | $209M | 4.7% |
| 693K | $200M | 4.5% |
| 411K | $196M | 4.4% |
| 87K | $172M | 3.9% |
| 549K | $166M | 3.7% |
| 68K | $155M | 3.5% |
| 118K | $136M | 3.1% |
| 349K | $130M | 2.9% |
| 352K | $105M | 2.4% |
| 197K | $95.1M | 2.1% |
| 226K | $85.3M | 1.9% |
| 114K | $82.3M | 1.8% |
| 278K | $66.2M | 1.5% |
| 167K | $59.6M | 1.3% |
| 212K | $54.2M | 1.2% |
| 124K | $43.7M | 1.0% |
| 102K | $42.9M | 1.0% |
| 43K | $41.8M | 0.9% |
| 4.67M | $37.9M | 0.9% |
ISHARES TR | 49K | $36.3M | 0.8% |
| 63K | $35.7M | 0.8% |
Diana Shipping (DSX)
507K shares in Q1 2026
Evommune (EVMN)
244K shares in Q1 2026
WORLD GOLD TR
145K shares in Q1 2026
Safe Bulkers (SB)
81K shares in Q1 2026
LyondellBasell (LYB)
65K shares in Q1 2026
CARNIVAL CORP
53K shares in Q1 2026
Akebia Therapeutics (AKBA)
41K shares in Q1 2026
AMICUS THERAPEUTIC
40K shares in Q1 2026
Invivyd (IVVD)
39K shares in Q1 2026
APELLIS PHARMACEUTICALS INC
23K shares in Q1 2026
HONEYWELL INTL INC
23K shares in Q1 2026
Anavex Life Sciences (AVXL)
18K shares in Q1 2026
Rocket Pharmaceuticals (RCKT)
18K shares in Q1 2026
Paypay (PAYP)
16K shares in Q1 2026
CoStar Group (CSGP)
15K shares in Q1 2026
Ars Pharmaceuticals (SPRY)
15K shares in Q1 2026
THOMSON REUTERS CORP
14K shares in Q1 2026
Abivax (ABVX)
14K shares in Q1 2026
Lexeo Therapeutics (LXEO)
13K shares in Q1 2026
Vanda Pharmaceuticals (VNDA)
12K shares in Q1 2026
Emergent Biosolutions (EBS)
11K shares in Q1 2026
SOLENO THERAPEUTICS INC
10K shares in Q1 2026
WISDOMTREE TR
7,229 shares in Q1 2026
Atlassian (TEAM)
5,378 shares in Q1 2026
Fabrinet (FN)
5,242 shares in Q1 2026
Pdd (PDD): $360M, or 8.1% of the portfolio reported for Q2 2026.
Between its last two 13F reports, E Fund Management Co., Ltd. opened 37 new positions, added to 193, trimmed 216 and sold out of 38. The comparison is in share counts, so a price move alone does not count as buying or selling.
Its 13F for Q2 2026 adds up to $4.46B. That is not the whole firm: a 13F lists only US-listed shares and some options held at the end of the quarter, and leaves out cash, bonds, short positions and foreign holdings.
The report for Q2 2026 was filed on Aug 11, 2026. A manager has 45 days after the end of each quarter to file, so the holdings are always several weeks old when they become public.
On 191 positions it reported as new or larger over 6 quarters, the typical one finished −1.9 points against the S&P 500 after 90 days, and 45% finished ahead of it. Measured from the day each filing became public; history, not a forecast.
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.